{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2018-09-11&answer.answeringMemberConstituency=Winchester&answeringDeptSortName=Health+and+Social+Care&registeredInterest=false", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?date=2018-09-11&answer.answeringMemberConstituency=Winchester&answeringDeptSortName=Health+and+Social+Care&registeredInterest=false", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2018-09-11&answer.answeringMemberConstituency=Winchester&answeringDeptSortName=Health+and+Social+Care&registeredInterest=false&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2018-09-11&_page=0&answer.answeringMemberConstituency=Winchester&answeringDeptSortName=Health+and+Social+Care&registeredInterest=false", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2018-09-11&answer.answeringMemberConstituency=Winchester&answeringDeptSortName=Health+and+Social+Care&registeredInterest=false", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2018-09-11&answer.answeringMemberConstituency=Winchester&answeringDeptSortName=Health+and+Social+Care&registeredInterest=false", "items" : [{"_about" : "http://data.parliament.uk/resources/971639", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/971639/answer", "answerText" : {"_value" : "<p>Departmental officials are in regular contact with Mylan, the United Kingdom licensed supplier of Epipens, as there have been ongoing supply issues affecting this product. Supplies are currently available of the 0.3mg, although limited, and are being closely managed to ensure that pharmacies can obtain stock to fulfil prescription for patients. Mylan anticipates that supplies will stabilize in the fourth quarter of 2018.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2018-10-09", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2018-10-09T17:02:17.267Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2018-09-11", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Allergies: Medical Equipment"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what the timeframe is to resolve the national shortage of EpiPen 0.3mg Auto-Injectors.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1513", "label" : {"_value" : "Biography information for Jo Swinson"}
      }
      , "tablingMemberConstituency" : {"_value" : "East Dunbartonshire"}
      , "tablingMemberPrinted" : [{"_value" : "Jo Swinson"}
      ], "uin" : "173542"}
    , {"_about" : "http://data.parliament.uk/resources/971667", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/971667/answer", "answerText" : {"_value" : "<p>According to the General Data Protection Regulation (GDPR), general practitioners (GPs) cannot charge patients or third parties for subject access to patient medical records, except where the request is manifestly unfounded or excessive and where the third party is an insurance company. Where the access request is deemed manifestly unfounded or excessive, the GP can either refuse the request or charge an appropriate administration charge for the work involved. Also, where the third party is an insurance company, the Access to Medical Reports Act (AMRA) 1988 would apply. The AMRA allows the GP to charge a reasonable fee to cover the cost of copying the report.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2018-10-09", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2018-10-09T16:56:41.003Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2018-09-11", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "General Practitioners: Data Protection"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, if he will clarify whether (a) pursuant to the Answer of 6 September 2018 to Question 168973, GP practices will not be allowed to charge third parties for subject access to patient medical records or (b) pursuant to the Answer of 12 July 2018 to Question 162134, the right of access under GDPR confers more personal information than is needed or is justified for insurance underwriting. Accordingly, insurance companies should instead use the established mechanism of the Access to Medical Reports Act 1988 (AMRA) to obtain summary medical reports from general practitioners (GPs).", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/298", "label" : {"_value" : "Biography information for Steve McCabe"}
      }
      , "tablingMemberConstituency" : {"_value" : "Birmingham, Selly Oak"}
      , "tablingMemberPrinted" : [{"_value" : "Steve McCabe"}
      ], "uin" : "173507"}
    , {"_about" : "http://data.parliament.uk/resources/971708", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/971708/answer", "answerText" : {"_value" : "<p>The World Health Organization Framework Convention on Tobacco Control (WHO FCTC) is not proposing a worldwide ban on advertising, promoting and sponsoring of e-cigarettes. The Government supports proportionate regulation of e-cigarettes to ensure non-smokers and children are protected from accessing these products, and has implemented the European Union Tobacco Products Directive which ensures such proportionate regulation.<\/p><p> <\/p><p>A search of the Department\u2019s Ministerial correspondence database has identified two items of correspondence received in the last six months about his Department's participation in the 8th Conference of the Parties (CoP) to the WHO FCTC in October 2018. This figure represents correspondence received by the Department\u2019s Ministerial correspondence unit only. The Department has also answered five Parliamentary Questions related to CoP in the last six months.<\/p><p> <\/p><p>As a global leader on tobacco control, the Department will engage constructively at the CoP, working closely with fellow members of the European Union and with other partners to continue to support measures proposed to reduce global harms from tobacco and ensure WHO FCTC Secretariat work proposals offer value for money.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2018-09-17", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "173549"}
        , {"_value" : "173550"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2018-09-17T14:00:27.737Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2018-09-11", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Electronic Cigarettes"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential effect of the WHO Framework Convention on Tobacco Control\u2019s proposal for a worldwide ban on advertising, promoting and sponsoring e-cigarettes on the Government\u2019s tobacco control plan; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1565", "label" : {"_value" : "Biography information for Sir Philip Davies"}
      }
      , "tablingMemberConstituency" : {"_value" : "Shipley"}
      , "tablingMemberPrinted" : [{"_value" : "Philip Davies"}
      ], "uin" : "173548"}
    , {"_about" : "http://data.parliament.uk/resources/971709", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/971709/answer", "answerText" : {"_value" : "<p>The World Health Organization Framework Convention on Tobacco Control (WHO FCTC) is not proposing a worldwide ban on advertising, promoting and sponsoring of e-cigarettes. The Government supports proportionate regulation of e-cigarettes to ensure non-smokers and children are protected from accessing these products, and has implemented the European Union Tobacco Products Directive which ensures such proportionate regulation.<\/p><p> <\/p><p>A search of the Department\u2019s Ministerial correspondence database has identified two items of correspondence received in the last six months about his Department's participation in the 8th Conference of the Parties (CoP) to the WHO FCTC in October 2018. This figure represents correspondence received by the Department\u2019s Ministerial correspondence unit only. The Department has also answered five Parliamentary Questions related to CoP in the last six months.<\/p><p> <\/p><p>As a global leader on tobacco control, the Department will engage constructively at the CoP, working closely with fellow members of the European Union and with other partners to continue to support measures proposed to reduce global harms from tobacco and ensure WHO FCTC Secretariat work proposals offer value for money.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2018-09-17", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "173548"}
        , {"_value" : "173550"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2018-09-17T14:00:27.803Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2018-09-11", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "WHO Framework Convention on Tobacco Control"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what representations he has received on his Department's participation in the 8th Conference of the Parties to the World Health Organisation Framework Convention on Tobacco Control in October 2018.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1565", "label" : {"_value" : "Biography information for Sir Philip Davies"}
      }
      , "tablingMemberConstituency" : {"_value" : "Shipley"}
      , "tablingMemberPrinted" : [{"_value" : "Philip Davies"}
      ], "uin" : "173549"}
    , {"_about" : "http://data.parliament.uk/resources/971710", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/971710/answer", "answerText" : {"_value" : "<p>The World Health Organization Framework Convention on Tobacco Control (WHO FCTC) is not proposing a worldwide ban on advertising, promoting and sponsoring of e-cigarettes. The Government supports proportionate regulation of e-cigarettes to ensure non-smokers and children are protected from accessing these products, and has implemented the European Union Tobacco Products Directive which ensures such proportionate regulation.<\/p><p> <\/p><p>A search of the Department\u2019s Ministerial correspondence database has identified two items of correspondence received in the last six months about his Department's participation in the 8th Conference of the Parties (CoP) to the WHO FCTC in October 2018. This figure represents correspondence received by the Department\u2019s Ministerial correspondence unit only. The Department has also answered five Parliamentary Questions related to CoP in the last six months.<\/p><p> <\/p><p>As a global leader on tobacco control, the Department will engage constructively at the CoP, working closely with fellow members of the European Union and with other partners to continue to support measures proposed to reduce global harms from tobacco and ensure WHO FCTC Secretariat work proposals offer value for money.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2018-09-17", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "173548"}
        , {"_value" : "173549"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2018-09-17T14:00:27.88Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2018-09-11", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "WHO Framework Convention on Tobacco Control"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what his Department's priorities are for the Eighth session of the Conference of the Parties to the World Health Organisation Framework Convention on Tobacco Control to be held in October 2018.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1565", "label" : {"_value" : "Biography information for Sir Philip Davies"}
      }
      , "tablingMemberConstituency" : {"_value" : "Shipley"}
      , "tablingMemberPrinted" : [{"_value" : "Philip Davies"}
      ], "uin" : "173550"}
    , {"_about" : "http://data.parliament.uk/resources/971761", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/971761/answer", "answerText" : {"_value" : "<p>The Department published a consultation on 10 August titled \u2018NICE's technology appraisal and highly specialised technology work programmes \u2013 Charging and Appeal Panels\u2019 which ran until 14 September 2018.<\/p><p> <\/p><p>Prior to the consultation, the Department and the National Institute of Health and Care Excellence (NICE) considered a number of options as well as charging. These are described in the consultation document and Impact Assessment which are published at the following link:<\/p><p> <\/p><p><a href=\"https://www.gov.uk/government/consultations/nice-recommendations-charging-and-appeal-panels\" target=\"_blank\">https://www.gov.uk/government/consultations/nice-recommendations-charging-and-appeal-panels<\/a><\/p><p> <\/p><p>The document also explains that based on current activity levels and the proposed charges, NICE expects it would generate £10 million per annum from charging and that, should charges be introduced, they would be reviewed after years one and two and periodically thereafter to ensure that there is no detrimental impact on the willingness of companies, including small companies, to launch products in the United Kingdom.<\/p><p> <\/p><p>The Government will carefully consider comments received in response to the consultation and will publish its response in due course.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2018-10-09", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "173640"}
        , {"_value" : "173641"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2018-10-09T17:00:54.877Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2018-09-11", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Medical Treatments"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what estimate he has made of the money that would be accrued to the public purse of the introduction of charges by NICE for companies whose products are selected for technology appraisal.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4249", "label" : {"_value" : "Biography information for Anne Marie Morris"}
      }
      , "tablingMemberConstituency" : {"_value" : "Newton Abbot"}
      , "tablingMemberPrinted" : [{"_value" : "Anne Marie Morris"}
      ], "uin" : "173639"}
    , {"_about" : "http://data.parliament.uk/resources/971762", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/971762/answer", "answerText" : {"_value" : "<p>The Department published a consultation on 10 August titled \u2018NICE's technology appraisal and highly specialised technology work programmes \u2013 Charging and Appeal Panels\u2019 which ran until 14 September 2018.<\/p><p> <\/p><p>Prior to the consultation, the Department and the National Institute of Health and Care Excellence (NICE) considered a number of options as well as charging. These are described in the consultation document and Impact Assessment which are published at the following link:<\/p><p> <\/p><p><a href=\"https://www.gov.uk/government/consultations/nice-recommendations-charging-and-appeal-panels\" target=\"_blank\">https://www.gov.uk/government/consultations/nice-recommendations-charging-and-appeal-panels<\/a><\/p><p> <\/p><p>The document also explains that based on current activity levels and the proposed charges, NICE expects it would generate £10 million per annum from charging and that, should charges be introduced, they would be reviewed after years one and two and periodically thereafter to ensure that there is no detrimental impact on the willingness of companies, including small companies, to launch products in the United Kingdom.<\/p><p> <\/p><p>The Government will carefully consider comments received in response to the consultation and will publish its response in due course.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2018-10-09", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "173639"}
        , {"_value" : "173641"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2018-10-09T17:00:54.94Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2018-09-11", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Medical Treatments"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what estimate he has made of the cost to the public purse in foregone (a) tax and (b) other revenues in the event that NICE introduces charges for technology appraisals and companies choose not to launch products in England.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4249", "label" : {"_value" : "Biography information for Anne Marie Morris"}
      }
      , "tablingMemberConstituency" : {"_value" : "Newton Abbot"}
      , "tablingMemberPrinted" : [{"_value" : "Anne Marie Morris"}
      ], "uin" : "173640"}
    , {"_about" : "http://data.parliament.uk/resources/971763", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/971763/answer", "answerText" : {"_value" : "<p>The Department published a consultation on 10 August titled \u2018NICE's technology appraisal and highly specialised technology work programmes \u2013 Charging and Appeal Panels\u2019 which ran until 14 September 2018.<\/p><p> <\/p><p>Prior to the consultation, the Department and the National Institute of Health and Care Excellence (NICE) considered a number of options as well as charging. These are described in the consultation document and Impact Assessment which are published at the following link:<\/p><p> <\/p><p><a href=\"https://www.gov.uk/government/consultations/nice-recommendations-charging-and-appeal-panels\" target=\"_blank\">https://www.gov.uk/government/consultations/nice-recommendations-charging-and-appeal-panels<\/a><\/p><p> <\/p><p>The document also explains that based on current activity levels and the proposed charges, NICE expects it would generate £10 million per annum from charging and that, should charges be introduced, they would be reviewed after years one and two and periodically thereafter to ensure that there is no detrimental impact on the willingness of companies, including small companies, to launch products in the United Kingdom.<\/p><p> <\/p><p>The Government will carefully consider comments received in response to the consultation and will publish its response in due course.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2018-10-09", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "173639"}
        , {"_value" : "173640"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2018-10-09T17:00:54.987Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2018-09-11", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Medical Treatments"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential effectiveness of options available to NICE other than charging for technology appraisals to tackle changes in the level of its central Government funding; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4249", "label" : {"_value" : "Biography information for Anne Marie Morris"}
      }
      , "tablingMemberConstituency" : {"_value" : "Newton Abbot"}
      , "tablingMemberPrinted" : [{"_value" : "Anne Marie Morris"}
      ], "uin" : "173641"}
    , {"_about" : "http://data.parliament.uk/resources/971811", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/971811/answer", "answerText" : {"_value" : "<p>In April 2012, the Secretary of State for Health and Social Care announced that £250 million would be invested to build proton beam therapy facilities at The Christie Hospital in Manchester and University College London Hospital (UCLH). Contracts were signed with Varian Medical Systems, Interserve Construction at The Christie, and Bouygues UK at UCLH at the end of July 2015. The Christie has been operational since 20 August 2018 and expects the first patients to be treated in the autumn. UCLH is currently on schedule to begin treating patients in summer 2020.<\/p><p> <\/p><p>NHS England does not hold information about high-energy proton beam provision in the private sector.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2018-10-09", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2018-10-09T16:53:23.383Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2018-09-11", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Radiotherapy"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what facilities in the UK offer high-energy proton beam cancer therapy treatment in (a) the NHS and (b) the private sector.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/114", "label" : {"_value" : "Biography information for Tim Loughton"}
      }
      , "tablingMemberConstituency" : {"_value" : "East Worthing and Shoreham"}
      , "tablingMemberPrinted" : [{"_value" : "Tim Loughton"}
      ], "uin" : "173485"}
    , {"_about" : "http://data.parliament.uk/resources/971813", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/971813/answer", "answerText" : {"_value" : "<p>NHS England has not funded any patients to have high-energy proton beam therapy in England and Wales in the last five years.<\/p><p> <\/p><p>Over the past five years, 895 National Health Service patients have been treated overseas with high-energy proton beam therapy at a total cost of just over £91 million. These figures include patients from England, Scotland and Northern Ireland but exclude patients from Wales. NHS England does not routinely split financial information between treatment and travel/subsistence costs. Further detail is provided in the following table.<\/p><p> <\/p><p> <\/p><table><tbody><tr><td><p> <\/p><\/td><td><p>2013/14<\/p><\/td><td><p>2014/15<\/p><\/td><td><p>2015/16<\/p><\/td><td><p>2016/17<\/p><\/td><td><p>2017/18<\/p><\/td><td><p>Total<\/p><\/td><\/tr><tr><td><p>Number of patients approved for referral<\/p><\/td><td><p>119<\/p><\/td><td><p>144<\/p><\/td><td><p>213<\/p><\/td><td><p>203<\/p><\/td><td><p>216<\/p><\/td><td><p>895<\/p><\/td><\/tr><tr><td><p>Total cost<\/p><\/td><td><p>£9.13 million<\/p><\/td><td><p>£12.63 million<\/p><\/td><td><p>£20.81 million<\/p><\/td><td><p>£24.51 million<\/p><\/td><td><p>£24.19 million<\/p><\/td><td><p>£91.27 million<\/p><\/td><\/tr><\/tbody><\/table><p><strong> <\/strong><\/p><p><strong> <\/strong><\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2018-10-09", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : {"_value" : "173487"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2018-10-09T16:56:45.747Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2018-09-11", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Radiotherapy"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, how many NHS England patients have been treated with high-energy proton beam cancer therapy in England and Wales in each of the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/114", "label" : {"_value" : "Biography information for Tim Loughton"}
      }
      , "tablingMemberConstituency" : {"_value" : "East Worthing and Shoreham"}
      , "tablingMemberPrinted" : [{"_value" : "Tim Loughton"}
      ], "uin" : "173486"}
    ], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2018-09-11&_page=1&answer.answeringMemberConstituency=Winchester&answeringDeptSortName=Health+and+Social+Care&registeredInterest=false", "page" : 0, "startIndex" : 1, "totalResults" : 12, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}